Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-03-31
2000-10-17
Sayala, Chhaya D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530399, A61K 3818
Patent
active
061332348
ABSTRACT:
Methods for treating vascular stenosis using hepatocyte growth factor ("HGF") are provided. In the methods, HGF can be administered to enhance re-surfacing of blood vessels damaged or traumatized, for instance, by vascular surgery or angioplasty. Articles of manufacture and kits containing HGF are also provided.
REFERENCES:
patent: 5227158 (1993-07-01), Jardieu
patent: 5316921 (1994-05-01), Godowski et al.
patent: 5328837 (1994-07-01), Godowski et al.
patent: 5589451 (1996-12-01), Wilson
patent: 5652225 (1997-07-01), Isner
patent: 5654404 (1997-08-01), Roos et al.
patent: 5686407 (1997-11-01), Clark et al.
patent: 5714461 (1998-02-01), Masunaga et al.
patent: 5736506 (1998-04-01), Naka
Asami et al., "Purification and Characterization of Hepatocyte Growth Factor from Injured Liver of Carbon Tetrachloride-Treated Rats" J. Biochem. 109:8-13 (1991).
Bottaro et al., "Identification of the Hepatocyte Growth Factor Receptor as the c-met Proto-Oncogene Product" Science 251:802-804 (Feb. 15, 1991).
Bussolino et al., "Hepatocyte Growth Factor is a Potent Angiogenic Factor Which Stimulates Endothelial Cell Motility and Growth" Journal of Cell Biology 119(3):629-641 (Nov. 1992).
Chan et al., "Identification of a Competitive HGF Antagonist Encoded by an Alternative Transcript" Science 254:1382-1385 (1991).
Chan et al., "Isoforms of Human HGF and Their Biological Activities" Hepatocyte Growth Factor-Scatter Factor (HGF-SF) and the C-Met Receptor, I.D. Goldberg and E.M. Rosen eds., Basel:Birkhauser Verlag pp. 67-79 (1993).
Comoglio, "Structure, Biosynthesis and Biochemical Properties of the HGF Receptor in Normal and Malignant Cells" Hepatocyte Growth Factor-Scatter Factor (HGF-SF) and the C-Met Receptor, I.D. Goldberg and E.M. Rosen eds., Basel:Birkhauser Verlag pp. 131-165 (1993).
Di Renzo et al., "Selective Expression of the Met-HGF Receptor in Human Central Nervous System Microglia" Oncogene 8:219-222 (1993).
Garabedian et al., "Recombinant Hepatocyte Growth Factor Accelerates Endothelial Cell Regrowth In Vivo Following Arterial Injury" Circulation (abstract only) 92(8):I-750 (Nov. 1995).
Giordano et al., "Transfer of Motogenic and Invasive Response to Scatter Factor/Hepatocyte Growth Factor by Transfection of Human met Protooncogene" Proc. Natl. Acad. Sci. USA 90:649-653 (Jan. 1993).
Gohda et al., "Purification and Partial Characterization of Hepatocyte Growth Factor from Plasma of a Patient with Fulminant Hepatic Failure" J. Clin. Invest. 81:414-419 (1988).
Grant et al., "Scatter Factor Induces Blood Vessel Formation In Vivo" Proc. Natl. Acad. Sci. USA 90:1937-1941 (1993).
Han et al., "Characterization of the DNF15S2 Locus on Human Chromosome 3: Identification of a Gene Coding for Four Kringle Domains with Homology to Hepatocyte Growth Factor" Biochemistry 30:9768-9780 (1991).
Hartmann et al., "A Functional Domain in the Heavy Chain of Scatter Factor/Hepatocyte Growth Factor Binds the c-Met Receptor and Induces Cell Dissociation but Not Mitogenesis" Proc. Natl. Acad. Sci. USA 89:11574-11578 (Dec. 1992).
Igawa et al., "Hepatocyte Growth Factor is a Potent Mitogen for Cultured Rabbit Renal Tubular Epithelial Cells" Biochem. & Biophys. Res. Comm. 174(2):831-838 (Jan. 31, 1991).
Ishida et al, "Hepatocyte Growth Factor for Prevention and Treatment of Thrombosis and Vascular Endothelial Cell Damage-Related Diseases" Chemical Abstracts (abstract No. 294033) 125(23):247 (Dec. 1996).
Kida et al., "Restenosis After Percutaneous Transluminal Coronary Angioplasty. Trial of Gene Therapy" Chemical Abstracts (abstract No. 192980) 124(15):3 (1996).
Lindroos et al., "Hepatocyte Growth Factor (Hepatopoietin A) Rapidly Increases in Plasma before DNA Synthesis and Liver Regeneration Stimulated by Partial Hepatectomy and Carbon Tetrachloride Administration" Hepatology 13(4):743-750 (1991).
Lokker and Godowski, "Generation and Characterization of a Competitive Antagonist of Human Hepatocyte Growth Factor, HGF/NK1" Journal of Biological Chemistry 268:17145-17150 (1993).
Lokker et al., "Structure-Function Analysis of Hepatocyte Growth Factor: Identification of Variants that Lack Mitogenic Activity Yet Retain High Affinity Receptor Binding" EMBO Journal 11(7):2503-2510 (1992).
Matsumoto et al., "Deletion of Kringle Domains or the N-Terminal Hairpin Structure in Hepatocyte Growth Factor Results in Marked Decreases in Related Biological Activities" Biochem. & Biophys. Res. Commun. 181(2):691-699 (Dec. 16, 1991).
Matsumoto et al., "Hepatocyte Growth Factor is a Potent Stimulator of Human Melanocyte DNA Synthesis and Growth" Biochem. & Biophys. Res. Commun. 176(1):45-51 (Apr. 15, 1991).
Michalopoulos et al., "Control of Hepatocyte Replication by Two Serum Factors" Cancer Research 44:4414-4419 (Oct. 1984).
Miyazawa et al., "An Alternatively Processed mRNA Generated from Human Hepatocyte Growth Factor Gene" European Journal of Biochemistry 197:15-22 (1991).
Miyazawa et al., "Molecular Cloning and Sequence Analysis of cDNA for Human Hepatocyte Growth Factor" Biochem. & Biophys. Res. Comm. 16(2):967-973 (Sep. 15, 1989).
Montesano et al., "Identification of a Fibroblast-Derived Epithelial Morphogen as Hepatocyte Growth Factor" Cell 67:901-908 (Nov. 29, 1991).
Naka et al., "Activation of Hepatocyte Growth Factor by Proteolytic Conversion of a Single Chain Form to a Heterodimer" The Journal of Biological Chemistry 267(28):20114-20119 (1992).
Nakamura et al., "Molecular Cloning and Expression of Human Hepatocyte Growth Factor" Nature 342:440-443 (Nov. 23, 1989).
Nakamura et al., "Partial Purification and Characterization of Hepatocyte Growth Factor from Serum of Hepatectomized Rats" Biochem. & Biophys. Res. Commun. 122:1450-1459 (Aug. 16, 1984).
Nakamura et al., "Purification and Characterization of a Growth Factor from Rat Platelets for Mature Parenchymal Hepatocytes in Primary Cultures" Proc. Natl. Acad. Sci. USA 83:6489-6493 (1986).
Nakamura et al., "Purification and Subunit Structure of Hepatocyte Growth Factor from Rat Platelets" FEBS Letters 224(2):311-316 (Nov. 1987).
Naldini et al., "Hepatocyte Growth Factor (HGF) Stimulates the Tyrosine Kinase Activity of the Receptor Encoded by the Proto-Oncogene c-MET" Oncogene 6:501-504 (1991).
Naldini et al., "Scatter Factor and Hepatocyte Growth Factor are Indistinguishable Ligands for the MET Receptor" EMBO Journal 10(10):2867-2878 (1991).
Okajima et al., "Primary Structure of Rat Hepatocyte Growth Factor and Induction of Its mRNA During Liver Regeneration Following Hepatic Injury" European Journal of Biochemistry 193:375-381 (1990).
Park et al., "Sequence of MET Protooncogene cDNA has Features Characteristic of the Tyrosine Kinase Family of Growth-Factor Receptors" Proc. Natl. Acad. Sci. USA 84:6379-6383 (1987).
Ponzetto et al., "c-met is Amplified But Not Mutated in a Cell Line with an Activated met Tyrosine Kinase" Oncogene 6:553-559 (1991).
Prat et al., "C-Terminal Truncated Forms of Met, the Hepatocyte Growth Factor Receptor" Molecular & Cellular Biology 11(12):5954-5962 (1991).
Rodrigues et al., "Alternative Splicing Generates Isoforms of the met Receptor Tyrosine Kinase Which Undergo Differential Processing" Molecular & Cellular Biology 11(6):2962-2970 (1991).
Rosen et al., "Purified scatter factor stimulates epithelial and vascular endothelial cell migration" Proc. Soc. Exp. Biol. Med. 195:34-43 (1990).
Rosen et al., "Scatter factor stimulates migration of vascular endothelium and capillary-like tube formation" Cell Motility Factors, I.D. Goldberg, Switzerland:Berkhauser Verlag pp. 76-88 (1991).
Rubin et al., "A Broad-Spectrum Human Lung Fibroblast-Derived Mitogen is a Variant of Hepatocyte Growth Factor" Proc. Natl. Acad. Sci. USA 88:415-419 (1991).
Russell et al., "Partial Characterization of a Hepatocyte Growth Factor From Rat Platelets" J. Cellular Physiology 119:183-192 (1984).
Seki et al., "Isolation and Expression of cDNA for Different Forms of Hepatocyte Growth Factor from Human Leukocyte" Biochem. and Biophys. Res. Commun. 172(1):321-327 (Oct. 15, 1990).
Stoker et al., "Scatter Factor is a Fibroblast-Derived Modulator of Epithelial Cell Mobility" Nature 32
Bunting Stuart
Gold Herman K.
Leinbach Robert C.
Schwall Ralph H.
Genentech Inc.
Kelber Steven B.
Sayala Chhaya D.
The General Hospital Corporation
LandOfFree
Methods and compositions for treating vascular stenosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for treating vascular stenosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for treating vascular stenosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-468923